会议专题

Efficacy and safety of FIREHAWK(R) abluminal groove filled biodegradable polymer sirolimus-eluting stent for the treatment of long coronary lesions: 9-month angiographic and 1-year clinical results from TARGET I trial long cohort

Background Previous studies indicate that long coronary lesion is one of the key predictors of DES failure.The FIM study showed initial evidence for the proof of concept with the novel FIREHAWK stent (MicroPort, Shanghai, China),an abluminal groove filled biodegradable polymer sirolimus-eluting stent.Consequently, a pivotal trial comparing FIREHAWK to XIENCE V stent (TARGET I, elinicaltrials.gov Identifier: 01196819) was initiated.TARGET I contains a randomized controlled cohort and a long stent registry cohort.The objective of the long cohort is to evaluate if FIREHAWK stent can produce similar results as observed in FIM study for the treatment of long coronary lesions.

XU Bo HUO Yong LI Wei Martin B.Leon GAO Run-lin ZIIANG Rui-yan WANG Hai-chang LI Zhan-quan YANG Yue-jin MA Chang-sheng HAN Ya-ling Alexandra J.Lansky

Fu Wai Hospital National Center for Cardiovascular Diseases,Beijing,China Peking University First Hospital,Beijing,China Columbia University Medical Center and Cardiovascular Research Foundation,New York,USA Affiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine,Shanghai,China Affiliated Xijing Hospital of the 4th Military Medical University,Xi”an,China Liaoning Provincial People”s Hospital,Shenyang,China Affiliated An Zhen Hospital of Capital Medical University,Beijing,China Shenyang Northern Hospital,Shenyang,China Yale New Haven Hospital,New Haven,USA

国内会议

第11届中国介入心脏病学大会

北京

英文

41-42

2013-03-20(万方平台首次上网日期,不代表论文的发表时间)